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Aneurysm
F.A. Lederle. Eur J Vasc Endovasc Surg 2012;43:254-6.
In a 1997 report of a large abdominal aortic aneurysm (AAA)
screening study, we observed a negative association between diabetes and
AAA. Although this was not previously described and negative associa-
tions between diseases are rare, the credibility of the finding was sup-
ported by consistent results in several previous studies and by the absence
of an obvious artefactual explanation. Since that time, a variety of studies
of AAA diagnosis, both by screening and prospective clinical follow-up,
have confirmed the finding. Other studies have reported slower aneurysm
enlargement and fewer repairs for rupture in diabetics. The seeming
protective effect of diabetes for AAA contrasts with its causal role in
occlusive vascular disease and so provides a strong challenge to the
traditional view of AAA as a manifestation of atherosclerosis. Research
focused on a protective effect of diabetes has already increased our
understanding of the etiology of AAA, and might eventually pave the way
for new therapies to slow AAA progression.
Total Endovascular Repair of Thoracoabdominal Aortic Aneurysms
Clough R.E., Modarai B., Bell R.E., Salter R., Sabharwal T., Taylor P.R.,
Carrell T.W. Eur J Vasc Endovasc Surg 2012;43:262-7.
Background: Endovascular graft designs incorporating sidebranches,
fenestrations and scallops offer a minimally-invasive alternative to open
surgery and hybrid approaches for thoracoabdominal aortic aneurysms
(TAAA). Our unit has offered total endovascular TAAA repair to selected
higher-risk patients since 2008. We report the largest UK series to date of
total endovascular TAAA repair.
Methods: Retrospective analysis of a prospectively-maintained opera-
tive database.
Results: 31 patients (21 male, 10 female) median age 71 years (range
58-84), with TAAA (12 Crawford type I, 13 type III, 6 type IV), median
diameter 6.4 (4.3 (mycotic)- 9.9) underwent endovascular TAAA repair
(total 48 sidebranches, 26 fenestrations, 13 scallops) between July 2008 and
January 2011.Median operating time 225 min (65–540 min), X-ray screen-
ing time 58 min (4–212 min), contrast dose 175 ml (70–500 ml), blood
loss 325 ml (100–400 ml). Median post-operative length of hospital stay 6
days (2–22 days). Three patients (3/31, 9.7%) died within 30 days of
operation: multisystem organ failure (1) acute renal failure and paraplegia
(1) and paraplegia (1). There were no other cases of in-hospital organ failure,
paraplegia or major complications. The median change in pre-discharge
from pre-operative renal function was 3.4% deterioration in eGFR (range:
32.7% deterioration to 73.0% improvement) One patient presented with
late-onset paraparesis, a second developed acute renal failure 8 months after
repair. One early high-pressure endoleak (type 3) required correction. Three
patients had died by median follow-up 12 months (1–36), 2 from heart
disease and one from haemopericardium secondary to acute dissection of the
ascending aorta (the dissection did not involve, nor extend close to, the
endovascular graft).
Conclusions: Total endovascular repair of TAAA offers patients a
minimally-invasive alternative to open surgery with early results at least
comparable to those seen with open or hybrid surgical approaches.
Analysis of Stroke after TEVAR Involving the Aortic Arch
Melissano G., Tshomba Y., Bertoglio L., Rinaldi E., Chiesa R. Eur J Vasc
Endovasc Surg 2012;43:269-75.
Objective: To analyse the incidence of stroke after thoracic endovas-
cular aortic repair (TEVAR) for aortic arch disease.
Methods: In the last decade, 393 patients received TEVAR at our
Institution; in 143 cases the aortic arch was involved (32 zones ‘0’, 35 zones
‘1’ and 76 zone ‘2’). The left subclavian artery (LSA) was revascularised
selectively in 75 cases; the proximal LSA was ligated or occluded with a plug
in 55 cases before endograft (EG) deployment.
Results: Initial clinical success, perioperative mortality, spinal cord
ischaemia and stroke in TEVAR patients with or without arch involvement
were, respectively, 86.7% vs. 94.4%, 4.2% vs. 2.4%, 2.1% vs. 3.6% and 2.8%
vs. 1.2%. The stroke rate was 9.4% (P 0.02) in ‘zone 0’, 0% in ‘zone 1’ and
1.3% in ‘zone 2’ with scans showing severe atheroma and/or thrombus in all
cases. Stroke was observed in patients with 2.6% or without 2.9% LSA
S
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888evascularisation; however, it was never observed in patients in whom the
SA was occluded before EG deployment and in 4.5% of patients in whom
t was patent at the time of EG deployment.
Conclusions: Stroke after TEVAR is not infrequent especially when
he arch is involved. Careful patient selection together with a strategy to
educe embolisation such as occlusion of supra-aortic trunks before EG
eployment may play a beneficial role.
atheter-based Radiofrequency Renal-nerve Ablation in Patients with
esistant Hypertension
zizi M., Steichen O., Frank M., Bobrie G., Plouin P.-F., Sapoval M. Eur J
asc Endovasc Surg 2012;43:293-9.
This review aims to describe the role and the results of catheter-based
enal nerve ablation for the treatment of resistant hypertension. Despite the
vailability of multiple classes of orally active antihypertensive treatments,
esistant hypertension remains an important public health issue in 2012 due
o its prevalence and association with target-organ damage and poor prog-
osis. The failure of purely pharmacological approaches to treat resistant
ypertension has stimulated interest in invasive device-based treatments
ased on old concepts. In the absence of orally active antihypertensive
gents, patients with severe and complicated hypertension were widely
reated by surgical denervation of the kidney until the 1960s, but this
pproach was associated with a high incidence of severe adverse events and a
igh mortality rate. A new catheter system using radiofrequency energy has
een developed, allowing an endovascular approach to renal denervation
nd providing patients with resistant hypertension with a new therapeutic
ption that is less invasive than surgery and can be performed rapidly under
ocal anaesthesia. To date, this technique has been evaluated only in open-
abel trials including small numbers of highly selected resistant hypertensive
atients with suitable renal artery anatomy. The available evidence suggests
favourable blood pressure-lowering effect in the short term (6months) and
low incidence of immediate local and endovascular complications. This
ollow-up period is, however, too short for the detection of rare or late-onset
dverse events. For the time being, the benefit/risk ratio of this technique
emains to be evaluated, precluding its uncontrolled and widespread use in
outine practice.
hen is Supervised Exercise Therapy Considered Useful in Peripheral
rterial Occlusive Disease? A Nationwide Survey among Vascular
urgeons
auret G.J., van Dalen H.C., Hendriks H.J., van Sterkenburg S.M.,
oelemayM.J., Zeebregts C.J., Peters R.J., Teijink J.A. Eur J Vasc Endovasc
urg 2012;43:308-12.
Objectives: Although international guidelines state that supervised
xercise therapy (SET) should be offered to all patients with intermittent
laudication (IC), SET appears to be underutilised in clinical practice. The
im of this study was to document current opinions of Dutch vascular
urgeons on SET as treatment option for peripheral arterial occlusive disease
PAOD).
Materials and methods: Vascular surgeons and fellows in vascular
urgery were asked to complete a 24-question survey either at the 2011
nnual Meeting of the Dutch Society for Vascular Surgery or online.
Results:Ninety-one participants, including 83 vascular surgeons (51% of
ll Dutch vascular surgeons), completed the survey. The respondents would
efer 75.4% of newly diagnosed patients with IC for SET. SET was considered
ess useful in patients with IC and major (cardiopulmonary) co-morbidity or a
ignificant iliac artery stenosis. In critical limb ischaemia, the combination of
ET and angioplasty was considered useful in 71.9%. Respondents regarded
atient satisfaction (63.3%) and improvement in pain-free or maximal walking
bility (26.6%) as clinically most relevant goals of SET. Most (84.4%) agreed
hat SET should also include lifestyle management.
Conclusion: Although the vast majority of Dutch vascular surgeons
onsider SET as an important treatment option for PAOD, SET should
eceive more emphasis in clinical practice since arguments not to refer for
ET are outdated. Furthermore, vascular surgeons agree that lifestyle man-
gement should be integrated in SET.
